Natascha Kleiter
7. July 2018 2024-10-08 13:11Natascha Kleiter
Natascha Kleiter,
Section of Translational Cell Genetics,
Medical University InnsbruckTitle: The nuclear orphan receptor NR2F6 as a new cancer immune checkpoint
Section of Translational Cell Genetics,
Medical University InnsbruckTitle: The nuclear orphan receptor NR2F6 as a new cancer immune checkpoint
Natascha Kleiter has characterized NR2F6 as an intracellular immune checkpoint, directly repressing transcription of cytokine genes in T cells relevant for cancer cell rejection and therefore enhancing tumor immune surveillance.
https://phd-school.i-med.ac.at/phd-programs/doctoralprogram/molecular-cell-biology
Related Posts
Ulrich Kalinke
Jun 15, 2023
125 views
Burkhard Ludewig
Apr 28, 2023
141 views
Clemens Schmitt
Sep 22, 2022
137 views
Matthias Ernst
Jun 02, 2022
131 views
Werner Held
Apr 22, 2022
124 views
Search
Categories